44 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Medalist Diversified REIT, Inc. MDRR shares jumped 196.5% to $3.41. Medalist Diversified REIT announced a dividend for the third quarter on its 8.0% Series A Cumulative Redeemable Preferred Stock in the amount of $0.5000 per share.
  • Interpace Biosciences, Inc. IDXG shares jumped 46.6% to $4.3697. Interpace Biosciences said the Audit Committee investigation found billing and compliance complaints unsubstantiated.
  • AnaptysBio, Inc. ANAB shares climbed 32.3% to $23.50 after Guggenheim upgraded the stock from Neutral to Buy and announced a price target of $36 per share. AnaptysBio yesterday reported positive topline data from GALLOP Phase 2 clinical trial of imsidolimab in moderate-to-severe generalized pustular psoriasis.
  • Allscripts Healthcare Solutions, Inc. MDRX shares gained 30.6% to $10.85 after the company agreed to sell its CarePort Health business to WellSky for $1.35 billion.
  • Novan Inc NOVN gained 29% to $0.59 after the company announced in vitro results showing the effect of NITRICIL against Covid-19.
  • VOXX International Corp VOXX rose 25.2% to $10.82 after the company swung to a profit in the second quarter.
  • Replimune Group, Inc. REPL gained 23.5% to $30.50.
  • Comstock Holding Companies, Inc. CHCI jumped 17.6% to $2.80.
  • NIO Limited NIO rose 16.3% to $25.14. JP Morgan upgraded NIO from Neutral to Overweight and announced a $40 price target. The company’s annual Nio Day, which is customarily held in December, has been pushed back and will be held Jan. 9, 2021.
  • OncoCyte Corp OCX shares jumped 15.8% to $1.69 after the company announced new prospective data demonstrating that treatment informed by DetermaRx significantly improves lung cancer survival.
  • Oblong Inc. OBLG shares gained 14.6% to $3.15. Oblong recently announced new patents for remote work to enhance current and planned multi-share collaboration offerings.
  • Genesis Healthcare, Inc. GEN rose 14% to $0.5958 after the company reported its subsidiary LTC ACO received positive reconciliation and settlement under the Medicare Shared Savings Program.
  • Eton Pharmaceuticals, Inc. ETON gained 12.3% to $7.78. Eton Pharma priced its 2.8 million shares at $7 per share.
  • Concho Resources Inc CXO rose 12.3% to $49.56. Bloomberg reported that Concophillips is in talks to acquire Concho.
  • Theravance Biopharma, Inc. TBPH gained 12% to $19.35. Morgan Stanley upgraded Theravance Biopharma from Equal-Weight to Overweight.
  • Betterware de Mexico, S.A.B. de C.V. BWMX climbed 11.8% to $24.52.
  • Centennial Resource Development, Inc. CDEV shares rose 11.3% to $0.6898 as the company reported that JP Morgan Chase Bank has reaffirmed borrowing base of $700 million. The company also reported liquidity increased by 6% versus the prior quarter.
  • EuroDry Ltd. EDRY climbed 10.6% to $4.59.
  • Energy Focus, Inc. EFOI gained 10% to $9.23. Energy Focus launched UV-C disinfection product portfolio offering airborne and surface disinfection solutions for commercial and residential indoor environments.
  • Viper Energy Partners LP VNOM gained 8.2% to $8.14 after the company announced its average Q3 production of barrels of oil per day. ScotiaBank also maintained its Sector Perform rating on the stock and raised its price target from $12 to $13 per share.
  • Hyliion Holdings Corp. HYLN rose 7.2% to $28.40 after Axioma disclosed a 10.82% active stake in the company.
  • Grubhub Inc. GRUB rose 6.2% to $80.53 after Just Eat Takeaway reported positive Q3 trends. Shareholders of Just Eat Takeaway.com NV recently approved a proposed acquisition of GrubHub.
  • Humanigen, Inc. HGEN rose 5.7% to $12.72. HC Wainwright & Co. initiated coverage on Humanigen with a Buy rating and announced a price target of $31.
  • Bed Bath & Beyond Inc. BBBY rose 5.4% to $23.34 after the company announced plans to sell its non-core assets.
  • Taiwan Liposome Company, Ltd. TLC shares rose 5.1% to $4.8441 as the company disclosed that it has enrolled first subject in Phase I clinical trial of inhalable anti-COVID-19 program.
  • GameStop Corp. GME shares rose 3.1% to $12.24 after Richard Mashaal’s hedge fund firm, Senvest Management LLC, purchased over 3.6 million common stock representing a 5.54% stake in GameStop last week.


Check out these big penny stock gainers and losers

Losers

  • Cyclerion Therapeutics, Inc. CYCN shares dipped 46.6% to $3.80 following a couple of clinical trial updates from the company. Cyclerion said its mid-stage investigational asset olinciguat did not show adequate activity to support further internal clinical development of it as a potential treatment for sickle cell disease. Separately, the company announced positive results from a Phase 1 translational pharmacology study of IW-6463, a soluble guanylate cyclase stimulator being developed for CNS disorders.
  • Enzo Biochem, Inc. ENZ fell 16.9% to $2.17. Enzo Biochem reported fourth-quarter revenues of $19.5 million, down 6.6% year-over-year, while on a GAAP basis, the net loss narrowed from 11 cents per share to 7 cents per share.
  • AMC Entertainment Holdings, Inc. AMC fell 15.5% to $2.99. The world’s biggest chain of theaters - AMC Entertainment is mulling options for respite from debt, that includes potential bankruptcy, Bloomberg reported.
  • Sorrento Therapeutics, Inc. SRNE fell 14.1% to $10.27. Sorrento Therapeutics yesterday said it has entered into an exclusive license agreement with Personalized Stem Cells, Inc. to acquire global rights to its adipose-derived mesenchymal stem cells for patients suffering from acute respiratory distress syndrome-associated with COVID-19.
  • Lazydays Holdings, Inc. LAZY dropped 13.8% to $14.48 after the company announced a common stock offering of 4 million shares.
  • Nxt-ID, Inc. NXTD shares fell 12.2% to $0.35 after climbing around 20% on Tuesday. Nxt-ID announced plans to adjourn the Annual Meeting of Stockholders.
  • Mercurity Fintech Holding Inc. MFH fell 10.5% to $2.65 after climbing over 18% on Tuesday.
  • Loop Industries, Inc. LOOP fell 10.2% to $7.03. Loop Industries shares tumbled around 33% on Tuesday after Hindenburg Researched released a negative short-seller report on the company. Loop Industries issued a response to Hindenburg Research's short report.
  • Wah Fu Education Group Limited WAFU fell 10% to $4.25 after declining over 31% on Tuesday.
  • Blonder Tongue Laboratories, Inc. BDR fell 9.3% to $1.36. Blonder Tongue shares jumped 34% on Tuesday after the company reported U.S. patent grant for its networking modules for display systems.
  • Dynavax Technologies Corporation DVAX dropped 8.8% to $4.735. Dynavax Technologies shares rose 12% on Tuesday after the company announced Medigen's COVID-19 vaccine combined with its CpG 1018 Adjuvant received Taiwan Government Subsidy.
  • Liquidia Technologies, Inc. LQDA fell 8.8% to $3.72. Liquidia Technologies reported that U.S. Patent Trial and Appeal Board has ruled against United Therapeutics on Tyvaso patents.
  • Celldex Therapeutics, Inc. CLDX shares declined 8.6% to $15.67. Celldex Therapeutics yesterday reported initiation of Phase 1b study of CDX-0159 in chronic spontaneous urticaria.
  • iBio, Inc. IBIO fell 8.2% to $2.0560 after reporting a decline in FY20 sales.
  • Enlivex Therapeutics Ltd. ENLV fell 7.5% to $12.83 after surging over 22% on Tuesday. Enlivex Therapeutics recently issued positive news related to the company's COVID-19 treatment.
  • JAKKS Pacific, Inc. JAKK dropped 7.5% to $4.06. JAKKS Pacific, last month, entered into a deal to create toy line based on Haribo products.
  • Altimmune, Inc. ALT dipped 6.8% to $13.25. Altimmune yesterday published positive pre-clinical data on its new COVID-19 vaccine candidate.
  • RAVE Restaurant Group, Inc. RAVE fell 6.5% to $0.7648. RAVE Restaurant Group, recently, announced hiring of two new executives to fuel franchise development.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksIntraday UpdateMarketsMoversTrading IdeasHealth CareInformation TechnologyInternet Software & ServicesMid-Day MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!